Please use a minimum of three unique search words
Our search is configured to only display links relevant to answer your question. For the best results please use specific and relevant keywords that accurately reflect the information you are seeking.
Please do not use this field to report adverse events or product complaints. Adverse events and product complaints should be reported. Reporting forms and information can be found at UK: www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store. Adverse events and product complaints should also be reported to Lilly: please call Lilly UK on 01256 315 000.
Trulicity ® (dulaglutide)
This information is intended for UK registered healthcare professionals only as a scientific exchange in response to your search for information.For current prescribing information for all Lilly products, including Summaries of Product Characteristics, Patient Information Leaflets and Instructions for Use, please visit: www.medicines.org.uk (England, Scotland, Wales) or www.emcmedicines.com/en-GB/northernireland/ (Northern Ireland).
What to do if the patient has missed a Trulicity® (dulaglutide) dose?
If a dulaglutide dose is missed, it should be administered as soon as possible if there are at least 3 days (72 hours) until the next scheduled dose.
UK_cFAQ_GLP035_MISSED_DOSE
en-GB
Instructions for a missed dose of dulaglutide
Dulaglutide is a human glucagon-like peptide-1 receptor agonist (GLP-1 RA) for once-weekly administration.1
If a dulaglutide dose is missed, the next dose depends on the remaining schedule (Instructions for a Missed Dose of Dulaglutide).1
If a dose of dulaglutide is missed and there are… |
Then… |
And... |
at least 72 hours until the next scheduled dose |
it should be administered as soon as possible |
patients can resume their regular once-weekly dosing schedule. |
less than 72 hours remaining before the next scheduled dose |
the missed dose should be skipped, the next dose should be administered on the regularly scheduled day, |
References
1Trulicity [summary of product characteristics]. Eli Lilly Nederland B.V., The Netherlands.
Date of Last Review: 10 June 2020
Contact Lilly
Call or Email us
If you want to ask a Medical Information question or you want to report an adverse event or product complaint you can call us or email us at ukmedinfo@lilly.com
Available Mon - Fri, 10am - 4pm, excluding Bank Holidays